Archives November 2020

Ian F. Deveau - Acting Division Director at FDA/CDER. Wearing a gray shirt with a red tye. The image is a close up showing his face down to his waist. Caption reads: “But I want to emphasize that while we need to move the needle to enhance the quality of compounded drugs, there are compounding facilities making quality drugs for patients who may need them.”
FDA Finalizes Insanitary Conditions Guidance for Compounding Facilities

The FDA has issued a statement with further emphasis on its intentions to increase enforcement against Insanitary conditions at compounding facilities.

All Eagle News , FDA
FDA Finalizes Insanitary Conditions Guidance for Compounding Facilities

The FDA has issued a statement with further emphasis on its intentions to increase enforcement against Insanitary conditions at compounding facilities.